Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report

被引:5
|
作者
Tamaki, Tomoaki [1 ]
Ohno, Tatsuya [1 ]
Kiyohara, Hiroki [1 ]
Noda, Shin-ei [1 ]
Ohkubo, Yu [1 ]
Ando, Ken [1 ]
Wakatsuki, Masaru [2 ]
Kato, Shingo [3 ]
Kamada, Tadashi [2 ]
Nakano, Takashi [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 3718511, Japan
[2] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan
[3] Saitama Med Univ Int Med Ctr, Hidaka, Saitama 3501298, Japan
关键词
Carbon-ion radiotherapy; Marginal recurrences; Cervical cancers; RADIATION-THERAPY; UPDATE;
D O I
10.1186/1748-717X-8-79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences. Patients with these recurrences have a chance of long-term survival by optimal re-treatment with radiotherapy. However, the re-irradiation often overlaps the initial and the secondary radiotherapy fields and can result in increased normal tissue toxicities in the bowels or the stomach. Carbon-ion radiotherapy, a form of particle beam radiotherapy using accelerated carbon ions, offers more conformal and sharp dose distribution than X-ray radiotherapy. Therefore, this approach enables the delivery of high radiation doses to the target while sparing its surrounding normal tissues. Marginal lymph node recurrences in common iliac lymph nodes after radiotherapy were treated successfully by carbon-ion radiotherapy in two patients. These two patients were initially treated with a combination of external beam radiotherapy and intracavitary and interstitial brachytherapy. However, the diseases recurred in the lymph nodes near the border of the initial radiotherapy fields after 22 months and 23 months. Because re-irradiation with X-ray radiotherapy may deliver high doses to a section of the bowels, carbon-ion radiotherapy was selected to treat the lymph node recurrences. A total dose of 48 Gy (RBE) in 12 fractions over 3 weeks was given to the lymph node recurrences, and the tumors disappeared completely with no severe acute toxicities. The two patients showed no evidence of disease for 75 months and 63 months after the initial radiotherapy and for 50 months and 37 months after the carbon-ion radiotherapy, respectively. No severe late adverse effects are observed in these patients. The two presented cases suggest that the highly conformal dose distribution of carbon-ion radiotherapy may be beneficial in the treatment of marginal lymph node recurrences after radiotherapy. In addition, the higher biological effect of carbon-ion radiotherapy and its superior dose distribution may provide more effective tumor control in treatment for re-irradiation of the marginal recurrences in radiation resistant tumors other than cervical cancer.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Carbon-Ion Radiotherapy Using Metal Artifact Reduction Computed Tomography in a Patient with Prostate Cancer with Bilateral Hip Prostheses: A Case Report
    Takakusagi, Yosuke
    Takayama, Yoshiki
    Kusano, Yohsuke
    Koge, Hiroaki
    Kano, Kio
    Shima, Satoshi
    Tsuchida, Keisuke
    Mizoguchi, Nobutaka
    Yoshida, Daisaku
    Kamada, Tadashi
    Miyakawa, Shin
    Imura, Koh
    Katoh, Hiroyuki
    CASE REPORTS IN ONCOLOGY, 2022, 15 (03): : 894 - 901
  • [42] Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)
    Noriyuki Okonogi
    Takuya Kaminuma
    Tomoaki Okimoto
    Makoto Shinoto
    Naoyoshi Yamamoto
    Shigeru Yamada
    Kazutoshi Murata
    Tatsuya Ohno
    Yoshiyuki Shioyama
    Hiroshi Tsuji
    Takashi Nakano
    Tadashi Kamada
    International Journal of Clinical Oncology, 2019, 24 : 1143 - 1150
  • [43] Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)
    Okonogi, Noriyuki
    Kaminuma, Takuya
    Okimoto, Tomoaki
    Shinoto, Makoto
    Yamamoto, Naoyoshi
    Yamada, Shigeru
    Murata, Kazutoshi
    Ohno, Tatsuya
    Shioyama, Yoshiyuki
    Tsuji, Hiroshi
    Nakano, Takashi
    Kamada, Tadashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (09) : 1143 - 1150
  • [44] Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer
    Okazaki, Shohei
    Shibuya, Kei
    Takura, Tomoyuki
    Miyasaka, Yuhei
    Kawamura, Hidemasa
    Ohno, Tatsuya
    CANCER SCIENCE, 2022, 113 (02) : 674 - 683
  • [45] Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
    Jakob Liermann
    Edgar Ben-Josef
    Mustafa Syed
    Juergen Debus
    Klaus Herfarth
    Patrick Naumann
    Strahlentherapie und Onkologie, 2022, 198 : 378 - 387
  • [46] Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancer
    Sato, Hiraku
    Kasuya, Goro
    Ishikawa, Hitoshi
    Nomoto, Akihiro
    Ono, Takashi
    Nakajima, Mio
    Isozaki, Yuka
    Yamamoto, Naoyoshi
    Iwai, Yuma
    Nemoto, Kenji
    Ichikawa, Tomohiko
    Tsuji, Hiroshi
    CANCER SCIENCE, 2021, 112 (09) : 3598 - 3606
  • [47] Should all cervical cancer patients with positive lymph node receive definitive radiotherapy: a population-based comparative study
    Wang, Yang
    Liu, Xingyu
    Liu, Jing
    Liu, Liying
    Ma, Yue
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2025, 311 (01) : 123 - 134
  • [48] Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer
    Hiroshima, Yuichi
    Ishikawa, Hitoshi
    Iwai, Yuma
    Wakatsuki, Masaru
    Utsumi, Takanobu
    Suzuki, Hiroyoshi
    Akakura, Koichiro
    Harada, Masaoki
    Sakurai, Hideyuki
    Ichikawa, Tomohiko
    Tsuji, Hiroshi
    CANCERS, 2022, 14 (16)
  • [49] Potential Pitfalls of a Fiducial Marker-matching Technique in Carbon-ion Radiotherapy for Lung Cancer
    Shiba, Shintaro
    Saitoh, Jun-Ichi
    Irie, Daisuke
    Shirai, Katsuyuki
    Abe, Takanori
    Kubota, Yoshiki
    Sakai, Makoto
    Okada, Ryosuke
    Ohno, Tatsuya
    Nakano, Takashi
    ANTICANCER RESEARCH, 2017, 37 (10) : 5673 - 5680
  • [50] Biochemical Failure after Carbon Ion Radiotherapy for Prostate Cancer
    Shimazaki, Jun
    Tsuji, Hiroshi
    Ishikawa, Hitoshi
    Kamada, Tadashi
    Harada, Masaoki
    Akakura, Koichiro
    Suzuki, Hiroyoshi
    Ichikawa, Tomohiko
    Tsujiii, Hirohiko
    ANTICANCER RESEARCH, 2012, 32 (08) : 3267 - 3273